Exercise Prior to Allogeneic Hematologic Stem Cell Transplantation
Exercise Therapy for Patients Awaiting Allogeneic Hematological Stem Cell Transplantation
1 other identifier
interventional
30
1 country
1
Brief Summary
The investigators hypothesize that inactivity during the search for a donor may exacerbate current deconditioned states; subsequently, influencing risk factors for post-transplant complications that hinder the recovery phase. This study is designed to investigate if exercise therapy administered prior to allogeneic hematologic stem cell transplantation (HSCT) can influence physical and psychological side-effects associated with HSCT. Approximately 6-weeks prior to HSCT, individuals will be randomized into either an exercise group or usual care group and followed until one year after HSCT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
October 16, 2014
CompletedFirst Posted
Study publicly available on registry
October 23, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2019
CompletedNovember 25, 2019
November 1, 2019
4.8 years
October 16, 2014
November 22, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Physical Function
Cardiopulmonary Capacity (VO2peak)
Baseline, 1 week pre HSCT, T100, 1yr post HSCT
Secondary Outcomes (8)
Change in Quality of Life
Baseline, 1 week pre HSCT, T100, 1yr post HSCT
Change in Symptoms
Baseline, 1 week pre HSCT, T100, 1yr post HSCT
Change in Anxiety
Baseline, 1 week pre HSCT, T100, 1yr post HSCT
Change in Depression
Baseline, 1 week pre HSCT, T100, 1yr post HSCT
Change in Fatigue
Baseline, 1 week pre HSCT, T100, 1yr post HSCT
- +3 more secondary outcomes
Other Outcomes (1)
Adherence to exercise sessions
One year
Study Arms (2)
Exercise
EXPERIMENTALIndividuals will participate in weekly supervised and unsupervised exercise sessions prior to HSCT, during hospitalization and till 100 days from HSCT. Exercise will consist of endurance and resistance exercise 3-5 days a week.
Usual Care
NO INTERVENTIONUsual care will have continue with standard of care treatment without any specific exercise instruction or guidance other than what is provided by the patient education team at the cancer centre.
Interventions
Eligibility Criteria
You may qualify if:
- Medical indication: allogeneic stem cell transplantation at Princess Margaret Hospital
- must be ambulatory without need for human assistance at time of recruitment
- medically cleared to exercise by the transplant physician
- demonstrates willingness to attend supervised sessions
- sufficient in English to ensure safety of understanding prescribed exercise guidelines, or has access to an adequate non-familial interpreter
You may not qualify if:
- another active malignancy
- less than 4 weeks till the scheduled HSCT
- refusal to be randomized
- does not have the approval of their transplant physician
- severe or unstable neurological, cardiorespiratory, musculoskeletal disease or mental illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Health Network, Torontolead
- Princess Margaret Hospital, Canadacollaborator
- Toronto Rehabilitation Institutecollaborator
Study Sites (1)
Princess Margaret Hospital & Toronto Rehabilitation Institute
Toronto, Ontario, M5T2M9, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeff Lipton, MD, PhD
Princess Margaret Hospital, University Health Network
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2014
First Posted
October 23, 2014
Study Start
October 1, 2014
Primary Completion
August 1, 2019
Study Completion
August 1, 2019
Last Updated
November 25, 2019
Record last verified: 2019-11